Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Macrogenics (MGNX) over the last 13 years, with Q3 2025 value amounting to $202.4 million.

  • Macrogenics' Total Non-Current Liabilities rose 4041.53% to $202.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $202.4 million, marking a year-over-year increase of 4041.53%. This contributed to the annual value of $143.6 million for FY2024, which is 131.71% down from last year.
  • Latest data reveals that Macrogenics reported Total Non-Current Liabilities of $202.4 million as of Q3 2025, which was up 4041.53% from $197.1 million recorded in Q2 2025.
  • Macrogenics' 5-year Total Non-Current Liabilities high stood at $234.0 million for Q1 2023, and its period low was $72.1 million during Q3 2022.
  • In the last 5 years, Macrogenics' Total Non-Current Liabilities had a median value of $141.9 million in 2024 and averaged $133.7 million.
  • In the last 5 years, Macrogenics' Total Non-Current Liabilities soared by 15165.59% in 2023 and then plummeted by 3936.33% in 2024.
  • Quarter analysis of 5 years shows Macrogenics' Total Non-Current Liabilities stood at $95.4 million in 2021, then surged by 44.91% to $138.2 million in 2022, then rose by 5.32% to $145.5 million in 2023, then decreased by 1.32% to $143.6 million in 2024, then skyrocketed by 40.94% to $202.4 million in 2025.
  • Its last three reported values are $202.4 million in Q3 2025, $197.1 million for Q2 2025, and $143.5 million during Q1 2025.